SteelPeak Wealth LLC Purchases 26,192 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

SteelPeak Wealth LLC grew its position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 4.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 568,176 shares of the company's stock after acquiring an additional 26,192 shares during the quarter. SteelPeak Wealth LLC owned about 1.13% of Astrana Health worth $17,619,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of ASTH. US Bancorp DE boosted its position in Astrana Health by 3,880.0% in the fourth quarter. US Bancorp DE now owns 4,776 shares of the company's stock worth $151,000 after purchasing an additional 4,656 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in Astrana Health by 5.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 471,329 shares of the company's stock worth $14,861,000 after purchasing an additional 23,533 shares during the last quarter. Victory Capital Management Inc. boosted its position in Astrana Health by 38.6% in the fourth quarter. Victory Capital Management Inc. now owns 62,116 shares of the company's stock worth $1,959,000 after purchasing an additional 17,310 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Astrana Health by 348.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 37,788 shares of the company's stock worth $1,191,000 after purchasing an additional 29,355 shares during the last quarter. Finally, Moran Wealth Management LLC boosted its position in Astrana Health by 21.5% in the fourth quarter. Moran Wealth Management LLC now owns 7,944 shares of the company's stock worth $250,000 after purchasing an additional 1,404 shares during the last quarter. Institutional investors own 52.77% of the company's stock.

Wall Street Analyst Weigh In

ASTH has been the topic of a number of recent research reports. Barclays initiated coverage on Astrana Health in a research report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price target on the stock. Truist Financial dropped their price target on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research report on Tuesday, March 18th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $53.29.

Astrana Health Stock Performance

Shares of NASDAQ:ASTH traded down $0.71 during midday trading on Friday, reaching $24.90. 310,514 shares of the company traded hands, compared to its average volume of 296,846. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.54. Astrana Health, Inc. has a 12 month low of $23.12 and a 12 month high of $63.20. The firm has a market capitalization of $1.40 billion, a price-to-earnings ratio of 34.58, a price-to-earnings-growth ratio of 0.94 and a beta of 0.84. The firm's fifty day moving average price is $25.99 and its two-hundred day moving average price is $30.43.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The company had revenue of $620.39 million for the quarter, compared to the consensus estimate of $628.11 million. Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The business's revenue for the quarter was up 53.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.31 earnings per share. On average, equities analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.